Key Record Dates Identifier: NCT02410512
Brief Title: A Study to Assess the Safety and Pharmacokinetics of MOXR0916 and Atezolizumab (Also Known as MPDL3280A or Anti-PD-L1) in Participants With Locally Advanced or Metastatic Solid Tumors

First Submitted : April 2, 2015
First Submitted that Met QC Criteria : April 2, 2015
First Posted : April 7, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : February 25, 2021
Last Update Posted : March 1, 2021